- Orios Venture Partners led the funding round with participation from existing investors -Blume Ventures, Leo Capital and Vishal Sampat.
- As is commonly known, a diabetes management program requires regular exercise, controlled diet, medicines and diagnostics and regular monitoring of blood sugar.
- The BeatO Glucometer connects to the user’s smartphone and works with the feature rich BeatO app.
- Once signed up, the user can order home delivery of medicines and diagnostics and BeatO’s range of specialty diabetes friendly food and drinks such as snacks, breakfast cereals, teas, juices and vinegars.
- It not only helps measure and monitor blood glucose over time, it also opens up to a world of made-for-diabetics FMCG products for breakfast, snacks, specialty food, and a whole marketplace of doctors, educators, diagnostics, medicines refills and insurance products.
Medical Device Startup BeatO Raises ₹ 11.75 Cr from Orios Venture Partners, others
20 March 2019 12:36 AM GMT
BeatO, the Delhi based health-tech start up, today announced the closure of its Pre-Series A round of�?�11.75 Crores (~US $1.714 million). Orios Venture Partners led the funding round with participation from�existing investors -Blume Ventures, Leo Capital and Vishal Sampat.� BeatO focuses on
Next Story
